Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/SCICLONE-PHARMACEUTICALS--119962474/nieuws/EpicentRx-kondigt-start-dosering-aan-in-China-voor-wereldwijde-fase-3-klinische-studie-REPLATINUM-N-41949755/?utm_source=whatsapp&utm_medium=social&utm_campaign=share